Compare SHEN & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHEN | CLPT |
|---|---|---|
| Founded | 1902 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.1M | 467.9M |
| IPO Year | 1994 | 2009 |
| Metric | SHEN | CLPT |
|---|---|---|
| Price | $10.06 | $8.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $27.50 | $21.50 |
| AVG Volume (30 Days) | 561.9K | ★ 638.9K |
| Earning Date | 10-28-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $357,854,000.00 | $36,971,000.00 |
| Revenue This Year | $4.66 | $31.18 |
| Revenue Next Year | $5.27 | $15.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.08 | ★ 17.78 |
| 52 Week Low | $9.13 | $8.12 |
| 52 Week High | $17.35 | $19.63 |
| Indicator | SHEN | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 35.39 |
| Support Level | $9.29 | N/A |
| Resistance Level | $10.48 | $11.93 |
| Average True Range (ATR) | 0.40 | 0.74 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 52.61 | 6.94 |
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.